Morepen Laboratories Ltd. reported unaudited standalone earnings results for the third quarter and nine months ended December 31, 2017. For the quarter, the company reported total revenue of INR 1,427.363 million compared to INR 1,390.488 million a year ago. Profit before exceptional item and tax was INR 96.711 million compared to INR 46.797 million a year ago. Profit before tax was INR 96.711 million compared to INR 46.797 million a year ago. Net profit for the period was INR 96.711 million compared to INR 46.797 million a year ago. Earnings of INR 0.21 per basic and diluted share compared to INR 0.09 per basic and diluted share a year ago. EBITDA grew by over 18% at INR 181.7 million compared to INR 153.4 million a year ago. Cash profit during the period rose by 32% at INR 172.7 million compared to INR 131.1 million a year ago. Net sales revenue was INR 1,398.7 million compared to INR 1,372.7 million a year ago. Expenditure was INR 1,245.7 million compared to INR 1,237.1 million a year ago. For the nine months, the company reported total revenue of INR 4,060.288 million compared to INR 4,036.294 million a year ago. Profit before exceptional item and tax was INR 220.084 million compared to INR 159.954 million a year ago. Profit before tax was INR 220.084 million compared to INR 159.954 million a year ago. Net profit for the period was INR 220.084 million compared to INR 159.954 million a year ago. Earnings of INR 0.48 per basic and diluted share compared to INR 0.34 per basic and diluted share a year ago. EBITDA was at INR 491.4 million compared to INR 474.8 million a year ago. Cash surplus was INR 456.4 million compared to INR 411.6 million a year ago. Net sales revenue was INR 3,968.7 million compared to INR 3,970.9 million a year ago. Expenditure was INR 3,568.9 million compared to INR 3,561.5 million a year ago.